Article
The activation mechanism and antibody binding mode for orphan GPR20
28 Feb 2023
Abstract excerpt
GPR20 is a class-A orphan G protein-coupled receptor (GPCR) and a potential therapeutic target for gastrointestinal stromal tumors (GIST) owing to its differentially high expression. An antibody-drug conjugate (ADC) containing a GPR20-binding antibody (Ab046) was recently developed in clinical trials for GIST treatment. GPR20 constitutively activates Gi proteins in the absence of any known ligand, but it remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
